Search results for abx831190

Girentuximab, Abbexa, abx831190

Girentuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CA9, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).